Skip to content

Medicare Changes for 2027: Drug Costs, Medicare Advantage and Negotiated Prices

The Part D cap rises to $2,400, 15 drugs get negotiated prices and Advantage premiums dip. What changes in Medicare in 2027 and what it means for you.

The short answer: In 2027 the yearly cap on Part D drug costs rises from $2,100 to $2,400, the maximum drug deductible goes from $615 to $700, and Medicare-negotiated prices take effect for 15 more drugs, including Ozempic, Wegovy and Rybelsus. Medicare Advantage premiums are expected to dip slightly on average. The 2027 Part B premium had not been announced when this article was written (October 2026).

Every fall I read the same announcements the insurance companies read, from CMS, the federal agency that runs Medicare. Most of it is technical. Below are the changes that actually reach people’s wallets in 2027, and what they mean in practice, in plain language.

How much will I pay for prescription drugs in 2027?

Pharmacist handing a prescription bag to a senior customer at the pharmacy counter
Part D (prescription drugs)20262027
Yearly out-of-pocket cap for covered drugs$2,100$2,400
Maximum drug deductible$615$700
Covered insulinup to $35 a monthup to $35 a month

The cap is the most important number for anyone taking expensive medications. Once your own spending on covered Part D drugs reaches $2,400 in 2027, you pay nothing more for covered drugs for the rest of the year. Because the cap is $300 higher than in 2026, a person with very expensive medications may pay up to $300 more over the year. Between the deductible and the cap, standard coverage means paying about 25% of a drug’s cost, though many plans use fixed copays instead.

For someone taking a few inexpensive generics, the cap rarely matters. What matters is the plan’s premium, its deductible and the copays for those specific drugs.

Note! If a large pharmacy bill early in the year worries you, the Medicare Prescription Payment Plan lets you spread your out-of-pocket drug costs into monthly payments over the year. Ask your plan how to sign up.

Which drugs have Medicare-negotiated prices starting January 1, 2027?

This is the second round of Medicare drug price negotiation. Starting January 1, 2027, negotiated prices apply to these 15 drugs:

DrugUsed mainly for
Ozempic, Rybelsus, Wegovy (semaglutide)Type 2 diabetes; Wegovy also for weight management and lowering heart risk
Tradjenta; Janumet, Janumet XRType 2 diabetes
Trelegy Ellipta; Breo ElliptaCOPD and asthma
XtandiProstate cancer
PomalystMultiple myeloma
IbranceBreast cancer
CalquenceChronic lymphocytic leukemia and lymphoma
OfevPulmonary fibrosis
LinzessChronic constipation, IBS with constipation
XifaxanLiver-related brain complications, IBS with diarrhea
Austedo, Austedo XRInvoluntary movements (tardive dyskinesia, Huntington’s chorea)
VraylarSchizophrenia, bipolar disorder, depression (add-on)
Otezla, Otezla XRPsoriasis, psoriatic arthritis

One important detail: the negotiated price is what Medicare and your plan pay, not what you pay at the counter. For a month of semaglutide (Ozempic) the negotiated price is about $274, compared with a 2024 list price of $959. Your own cost depends on your plan’s tier for the drug and on where you are in the year. In practice, a lower price can mean lower coinsurance and reaching the $2,400 cap later, or not at all.

Coverage still depends on why a drug is prescribed. Medicare drug plans generally can’t cover drugs used only for weight loss, so before you assume anything, check how your plan covers your specific prescription.

What changes in Medicare Advantage for 2027?

According to data CMS published on September 28, 2026:

  • the average monthly Medicare Advantage premium is expected to fall from $14.37 to about $12,
  • about 5,500 plans will be offered nationwide, and 97% of people with Medicare can choose from 10 or more,
  • roughly 8 in 10 current members can stay in their plan with the same or a lower premium,
  • extra benefits such as dental, vision and hearing are expected to stay stable on average.

Averages are useful for headlines, not for decisions. In the Chicago area there are many plans to choose from, which is good news, but it also means more letters, ads and phone calls this fall. What counts is whether your doctors, hospital and prescriptions fit a given plan.

What about stand-alone drug plans?

If you have Original Medicare with a separate Part D plan, pay attention this year. The average stand-alone drug plan premium is expected to rise slightly, from $35.09 to about $36 a month. A temporary federal program that held these premiums down ends in 2027, so prices will vary more from plan to plan. That’s a good reason to compare your drug plan this fall, even if you’re happy with your Medigap policy.

Will telehealth still be covered?

Yes. Congress extended Medicare’s telehealth flexibilities through December 31, 2027. Many visits can still be done by video, including from home, and some by phone, for example follow-up visits and mental health care.

What hasn’t been announced yet?

As of early October 2026, CMS had not yet published the 2027 Part B premium or the Part A and Part B deductibles. For comparison, the standard Part B premium in 2026 is $202.90 a month. These figures are usually announced in late October or November, and we will update this article when they are.

What should I do with this information?

  • Read your plan’s Annual Notice of Change and mark what changes for you.
  • Check whether any of your drugs are on the negotiated list and how your plan will cover them in 2027.
  • If you take expensive medications, compare the total yearly cost, not just the premium.
  • If you have a stand-alone drug plan, compare it during open enrollment, October 15 to December 7.

How I can help

At a free consultation in our office at 3410 N. Harlem Ave. or 6500 W. Archer Ave., or by phone, I go through your medications one by one and show you what they would cost in 2027 under your current plan and under the other plans available to you. The first meeting takes about 30 minutes. (773) 620-5258.

Olivier Wasilewski
Independent insurance broker, founder of Medicare On The Spot. Nearly 20 years in Medicare, including UnitedHealthcare's Medicare division as manager of independent agents and director of ethnic markets for Illinois. Licensed in: IL, FL, AZ, WI, CO, IN, TX, MI, CT, NV, TN, WA, NC, SC, MO, OK, UT.
Last updated: October 2026

This article was prepared with the help of AI tools, then reviewed and approved by Olivier Wasilewski, licensed insurance broker.

Common questions about Medicare in 2027

Will Ozempic cost me $274 a month in 2027?

No. That’s the price Medicare and the plan pay. What you pay depends on your plan’s tier for the drug, your deductible and how much you’ve already spent that year.

Is the $2,400 cap per person or per household?

Per person. Each person’s spending on covered Part D drugs is counted separately.

Does my premium count toward the $2,400 cap?

No. Only your out-of-pocket costs for covered Part D drugs count. Premiums and drugs not covered by your plan don’t.

When will the 2027 Part B premium be known?

CMS usually announces it in late October or November. We will add the figures to this article once they’re published.

Sources

  1. CMS press release, Sept. 28, 2026: Medicare Advantage and Medicare Prescription Drug Programs Expected to Remain Stable in 2027
  2. CMS: CY 2027 Rate Announcement, April 6, 2026, Attachment V (Part D deductible and out-of-pocket threshold)
  3. CMS: Fact sheet: Negotiated prices for initial price applicability year 2027 (Nov. 2025)
  4. CMS: Selected drugs and negotiated prices
  5. HHS: Telehealth policy: Medicare telehealth flexibilities through December 31, 2027
  6. Medicare.gov: Open Enrollment

Leave a Reply

Your email address will not be published. Required fields are marked *